MMJ Recs

AUGUST 1, 2024

Cannabis can significantly enhance quality of life by managing chronic pain, alleviating nausea and vomiting, stimulating appetite, improving sleep, and supporting mental health. Medical marijuana can improve sleep quality by addressing these underlying issues.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

The Cannigma

JUNE 15, 2021

It certainly has many potential benefits, but you should differentiate between what people say CBD is good for and what clinical research suggests it may do, as the two are not always aligned. . Many people use CBD to help them sleep, relieve anxiety, or both. Sonya Yruel/Drug Policy Alliance).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Project CBD

NOVEMBER 11, 2023

Others say if they use before bedtime, they can’t sleep, they stay awake all night. We rate levels of evidence, and a high level may be a controlled randomized clinical trial (RCT), but there are also observational studies. The other problem with cannabis is that there’s a wide range of individual responses to it.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

The Cannigma

MARCH 12, 2021

And he’s looking at it and all these words are coming out, cannabinoids, THC, CBD, ratios, terpenes, and the customer realizes they have no idea what they’re doing. They want also maybe CBD and they want terpenes and they want other cannabinoids in there. and those are intertwined in – they do want THC, but not just THC.

Legalization 130

Legalization Patients Education Dispensary 130

Cannabis Law Report

NOVEMBER 24, 2021

Research into the plant’s chemical compounds has also revealed a rich array of terpenes and flavonoids that may also account for the plant’s therapeutic effects (Kotsirilos and McGregor 2021 ). Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. Conditions most frequently mentioned.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Amanda Feilding, Countess of Wemyss and March is an English drug policy reformer, lobbyist and research coordinator. Andrew Yang.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51